TCD Royalty Sub LP

General

Total Cases5

Active Cases--

Patents--

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
05/16/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	ORDER of USCA as to 202 Notice of Appeal (Federal Circuit) filed by Galderma Laboratories L.P., TCD Royalty Sub LP. Decision of USCA: The motion for an injunction pending appeal is denied. The motion to expedite is granted to the extent provided in this order (see order for further details). (jfm) (Entered: 05/16/2024)
04/22/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	EXHIBIT re 191 Redacted Document by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A1-A300)(Haney, Megan) (Entered: 04/22/2024)
04/22/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	Remark: D.I. 218 Memorandum Opinion and D.I. 219 Order have been unsealed per Chamber's directive. (vfm) (Entered: 04/22/2024)
04/19/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding the parties have no redactions to the Court's Opinion and Order (D.I. 218, 219). (Phillips, John) (Entered: 04/19/2024)
04/19/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	REDACTED VERSION of 217 Reply Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/19/2024)
04/19/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	REDACTED VERSION of 209 Reply Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/19/2024)
04/19/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	REDACTED VERSION of 205 Declaration by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits A-K)(Tigan, Jeremy) (Entered: 04/19/2024)
04/19/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	REDACTED VERSION of 216 Declaration,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37)(Phillips, John) (Entered: 04/19/2024) REDACTED VERSION of 216 Declaration,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37)(Phillips, John) (Entered: 04/19/2024)
04/19/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	REDACTED VERSION of 204 Opening Brief in Support, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Tigan, Jeremy) (Entered: 04/19/2024)
04/19/24	Galderma Laboratories LP v. Lupin Inc 1:21-CV-01710 ( D. DE )	REDACTED VERSION of 215 Declaration by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/19/2024)